NCT00002236已完成不适用
An Open-Label, Parallel Group, Pilot Study of Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of BID and TID Regimens of Delavirdine Mesylate, Zidovudine, and Indinavir Sulfate in HIV-1 Infected Individuals
Pharmacia and Upjohn11 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 32
- 试验地点
- 11
研究概览
简要总结
The purpose of this study is to see whether it is better to take delavirdine (DLV) plus indinavir (IDV) plus zidovudine (ZDV) twice a day or three times a day.
详细描述
Patients are divided into 2 treatment groups; the groups are balanced with respect to viral load. Group A receives ZDV, DLV, and IDV 3 times daily. Group B receives ZDV, DLV, and IDV 2 times daily. Patients are evaluated for changes from baseline in viral load and CD4 cell count.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 14 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •You may be eligible for this study if you:
- •Are HIV-positive.
- •Have a viral load (level of HIV in the blood) of at least 20,000 copies/ml.
- •Have a CD4 cell count of at least 50 cells/mm
- •Are at least 14 years old (consent of parent or guardian is required if under 18).
排除标准
- •You will not be eligible for this study if you:
- •Have ever taken an anti-HIV drug other than ZDV.
- •Have taken ZDV for more than 1 month.
研究者
研究点 (11)
Loading locations...
相似试验
Unknown
2 期
The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention TreatmentHIV InfectionsNCT00005118Merck Sharp & Dohme LLC100
Unknown
2 期
Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice DailyHIV InfectionsNCT00002241Merck Sharp & Dohme LLC80
Unknown
2 期
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV DrugsHIV InfectionsNCT00002451Merck Sharp & Dohme LLC8
已完成
不适用
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected PatientsHIV InfectionsNCT00002401Pharmacia and Upjohn160
已完成
3 期
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With NelfinavirHIV InfectionsNCT00002220Merck Sharp & Dohme LLC120